About

HIV Impact Network for Vertical Transmission Elimination

As part of global efforts to address the need for more effective action in eliminating pediatric HIV infections and ending AIDS in children by 2030, the Gates Foundation has funded ICAP at Columbia University and Paediatric-Adolescent Treatment Africa (PATA)  to implement an HIV Impact Network for Vertical Transmission Elimination (the HIVE project).

Who We Are

The HIVE project leverages the global expertise of ICAP at Columbia University’s technical staff in New York and regionally across Africa.

HEADQUARTERS
REGIONAL
PARTNERS

Peter Preko, MBChB, MPH

Principal Investigator

Over 20 years of experience promoting patient-centered and quality care in HIV programs.

Peter Preko, MBChB, MPH

Principal Investigator

Over 20 years of experience promoting patient-centered and quality care in HIV programs.

Elaine Abrams, MD

Senior Research Director

Elaine Abrams, MD

Senior Research Director

Ruby Fayorsey, MD, MPH

Deputy Director, ICAP Clinical and Laboratory Unit

Ruby Fayorsey, MD, MPH

Deputy Director, ICAP Clinical and Laboratory Unit

William Reidy, PhD, MPH

Deputy Director (Strategic Information)

William Reidy, PhD, MPH

Deputy Director (Strategic Information)

Karampreet Sachathep, PhD

Senior Strategic Information Manager

Karampreet Sachathep, PhD

Senior Strategic Information Manager

Laura Block, MSc

Deputy Director (Management and Operations)

Laura Block, MSc

Deputy Director (Management and Operations)

Jennifer Zech, MSc

Special Projects Coordinator

Jennifer Zech, MSc

Special Projects Coordinator

Efua Owusu, MS

Senior Communications Officer

Efua Owusu, MS

Senior Communications Officer

Franklin Emerenini, MBBS, MSc, FMCPaed

Deputy Director

Franklin Emerenini, MBBS, MSc, FMCPaed

Deputy Director

Laurian Katengesha, MD, MPH, MSc

Regional Strategic Information Advisor

Laurian Katengesha, MD, MPH, MSc

Regional Strategic Information Advisor

Bernadeta Msongole, MD, MPH

Regional Clinical Advisor

Bernadeta Msongole, MD, MPH

Regional Clinical Advisor

Lulu Ndapatani, MPH, BSN

Regional Clinical Advisor

Lulu Ndapatani, MPH, BSN

Regional Clinical Advisor

Maureen Syowai, MBChB, MSc

Deputy Director (Clinical/Technical)

Maureen Syowai, MBChB, MSc

Deputy Director (Clinical/Technical)

John Bosco Matovu, MBChB, MPH, MSc

Regional Clinical Advisor and dHTS Lead

John Bosco Matovu, MBChB, MPH, MSc

Regional Clinical Advisor and dHTS Lead

Rachel Mudekereza, MD, MPH

Senior Regional Clinical Advisor, West and Central Africa

Rachel Mudekereza, MD, MPH

Senior Regional Clinical Advisor, West and Central Africa

Rudo A.P. Kuwengwa, MD, MPH

Regional Clinical Advisor

Rudo A.P. Kuwengwa, MD, MPH

Regional Clinical Advisor

Violet Oramisi, MBChB, MSc

Regional Strategic Information Advisor

Violet Oramisi, MBChB, MSc

Regional Strategic Information Advisor

Marline Jumbe-Kumbe, MA, MSc

Regional Strategic Information Advisor

Marline Jumbe-Kumbe, MA, MSc

Regional Strategic Information Advisor

Onyekachi Ukaejiofo, MBBS, MSc

Regional Clinical and Quality Improvement Advisor

Onyekachi Ukaejiofo, MBBS, MSc

Regional Clinical and Quality Improvement Advisor

Christine Mburu

Regional Operations Manager

Christine Mburu

Regional Operations Manager

Susan Matheka, BA

Project Assistant

Susan Matheka, BA

Project Assistant

Phephile Dlamini

Project Operations Coordinator

Phephile Dlamini

Project Operations Coordinator

Matildah Chisanga

Regional Project Operations Coordinator (Admin & Finance)

Matildah Chisanga

Regional Project Operations Coordinator (Admin & Finance)

Focus Areas

The two-year HIVE project is a partnership with ministries of health and other key stakeholders, including the Global Alliance to End AIDS in Children by 2030. HIVE aims to decrease vertical transmission of HIV in children in Kenya, Mozambique, Nigeria, South Africa, Tanzania, and Zambia.  Specific focus areas will include closing the testing, treatment and retention gap for pregnant and breastfeeding women living with HIV as well as early testing and linkage to treatment for infants and to eliminate vertical transmission and keep mothers and their children healthy.